# [Histomoniasis (Blackhead Disease) in Turkeys](/knowledge/parasites/avian-parasites/histomoniasis-blackhead-disease-turkeys-lifecycle-prevention): Etiology, Pathology, and Control ## Key Takeaways - Histomoniasis, caused by the protozoan *Histomonas meleagridis*, is a severe disease in turkeys characterized by necrotizing typhlitis and hepatitis, often leading to mortality exceeding 50%. - Transmission primarily occurs via ingestion of embryonated *Heterakis gallinarum* eggs containing the parasite, or through earthworms acting as transport hosts; direct cloacal transmission is also a confirmed route. - Pathological hallmarks include thickened, ulcerated ceca with caseous cores and focal, circular necrotic lesions in the liver, often described as "target-like." - Turkeys exhibit a high susceptibility due to a delayed and insufficient gut immune response, contrasting with the more robust response observed in chickens, which often act as asymptomatic carriers. - Control strategies are challenged by the removal of effective chemotherapeutics; current approaches focus on integrated management, including *Heterakis* nematode control, strict biosecurity, and the development of live attenuated vaccines. - Diagnosis relies on clinical signs (depression, sulfur-yellow diarrhea), characteristic gross and histopathological lesions, and molecular methods like PCR for detecting *H. meleagridis* DNA. --- ## Introduction Histomoniasis, commonly known as blackhead disease, is a re-emerging and economically significant protozoan disease of turkeys caused by the flagellate *[Histomonas meleagridis](/knowledge/parasites/avian-parasites/histomonas-meleagridis-blackhead-disease-turkeys)* [1]. The disease is characterized by necrotizing typhlitis and hepatitis, with mortality rates in turkey flocks often exceeding 50% [1, 2]. The removal of effective prophylactic and therapeutic compounds from the market has led to a resurgence of histomoniasis in major turkey-producing regions, making it a critical concern for the poultry industry [1, 3]. This article provides a detailed review of the etiology, life cycle, pathology, immune response, diagnostic methods, and control strategies for *H. meleagridis* infection in turkeys. ## Etiology and Taxonomy *[Histomonas meleagridis](/knowledge/parasites/avian-parasites/histomonas-meleagridis-turkeys-diagnosis-therapeutic-options)* is a pleomorphic, flagellated protozoan parasite belonging to the order Tritrichomonadida within the phylum Parabasalia [1]. The organism exists in two primary morphological forms: a flagellated trophozoite found in the cecal lumen and a non-flagellated, amoeboid form that invades tissues [1]. The trophozoite is approximately 8 to 15 µm in diameter and typically possesses a single nucleus and a single flagellum, though multiflagellate forms have been observed [1]. The amoeboid form is capable of phagocytosis and is responsible for the invasive, pathogenic phase of the infection [1]. A recent molecular investigation in Hungary identified a new species closely related to *H. meleagridis* in turkeys and pheasants, suggesting that the genetic diversity of histomonads in avian hosts may be greater than previously recognized [4]. ## Life Cycle and Transmission The life cycle of *H. meleagridis* is direct, but the parasite is highly fragile outside the host and relies on a transport host for environmental survival [1]. The primary vector is the cecal nematode *[Heterakis gallinarum](/knowledge/parasites/avian-parasites/heterakis-gallinarum-cecal-worm-histomonas-vector)*, within whose eggs *H. meleagridis* can survive for extended periods [1]. Turkeys become infected through the ingestion of embryonated *H. gallinarum* eggs containing the protozoan, or by ingesting earthworms that have consumed these eggs [1]. This vector-borne transmission is the principal route of infection in commercial and backyard flocks. For a detailed description of the *[Heterakis gallinarum](/knowledge/parasites/avian-parasites/heterakis-gallinarum-cecal-worm-histomonas-vector)* life cycle, see the article on [Respiratory and Intestinal Nematodes of Poultry](/knowledge/parasites/avian-parasites/poultry-nematodes-syngamus-ascaridia-heterakis-capillaria). Direct cloacal infection is another experimentally confirmed route of transmission [5]. Rapid transmission of *H. meleagridis* has been demonstrated in turkeys and specific pathogen free chickens following cloacal infection with a mono-eukaryotic culture, indicating that direct bird-to-bird transmission via the cloaca can occur, particularly in floor-reared flocks where birds have access to fresh droppings [5]. This route may be especially relevant in the absence of the nematode vector [5]. ## Pathogenesis and Pathology Following ingestion, *H. meleagridis* excysts in the lower intestinal tract and colonizes the ceca [1]. The amoeboid form invades the cecal mucosa, causing a severe, necrotizing typhlitis [1, 6]. The cecal walls become thickened, ulcerated, and filled with a caseous, cheese-like core [1]. The parasite then migrates via the portal circulation to the liver, where it induces focal to coalescing necrotic hepatitis [1]. Hepatic lesions are characteristically circular, depressed, and yellow-green to gray in color, often described as "target-like" [1]. The severity of pathology is influenced by host species, age, and concurrent infections [6, 7, 8]. Turkeys are highly susceptible, whereas chickens are more resistant and often serve as asymptomatic carriers [1, 9]. Co-infection with *Salmonella* has been shown to worsen *H. meleagridis* infection in turkeys, leading to more severe clinical signs and lesion scores [7]. Similarly, co-infection with *Eimeria* species and *Escherichia coli* disrupts the gut microbiota, suppresses inflammation, and impairs bone health in turkey poults challenged with *H. meleagridis* [8]. The presence of *E. coli* in the gut is affected by *H. meleagridis* induced typhlitis, which alters the relative but not the absolute *E. coli* counts and invasion in the gut [6]. A novel objective quantitative tool using Evans Blue Dye has been developed for lesion scoring in *H. meleagridis* infected poultry, providing a more reproducible method for assessing pathology compared to subjective visual scoring [10]. Serum biochemistry of turkeys challenged with *H. meleagridis* reveals significant alterations in liver enzymes and other metabolites, reflecting the extent of hepatic damage [11]. ## Immune Response The immune response to *H. meleagridis* differs markedly between turkeys and chickens [9]. Turkeys fail to mount an effective early immune response in the gut, characterized by a delayed and insufficient influx of lymphocytes and macrophages at the site of infection [9]. This immunological deficit is a key factor in the high susceptibility of turkeys to histomoniasis [9]. In contrast, chickens mount a more robust and rapid cellular immune response, which limits tissue invasion and pathology [9]. Vaccination studies have provided insights into the protective immune mechanisms [12, 13, 14, 15]. Vaccination with live attenuated strains of *H. meleagridis* limits pronounced changes in B cells and T-cell subsets in both turkeys and chickens [12]. A clonal monoxenic *H. meleagridis* vaccine has been shown to provide long-term protection in turkeys [15]. An *in vitro* attenuated strain of *H. meleagridis* provides cross-protective immunity in turkeys against heterologous virulent isolates, suggesting that a single vaccine strain may protect against diverse field strains [13]. Intracloacally passaged low-virulent *H. meleagridis* also protects turkeys from histomonosis [16]. Furthermore, *H. meleagridis* passaged *in vitro* resulted in reduced pathogenicity and is capable of protecting turkeys from subsequent challenge [14]. ## Biochemical and Molecular Characteristics *[Histomonas meleagridis](/knowledge/parasites/avian-parasites/histomonas-meleagridis-blackhead-disease-turkeys)* is a microaerophilic to anaerobic organism that relies on hydrogenosomal metabolism for energy production [17]. A flavodiiron protein from *H. meleagridis* has been biochemically characterized, with superoxide identified as a reaction intermediate [17]. This protein likely plays a critical role in the parasite's defense against oxidative stress within the host [17]. The molecular characterization of *H. meleagridis* and related species continues to advance, with molecular investigations revealing the endemicity of new species closely related to *H. meleagridis* in turkeys and pheasants [4]. ## Diagnosis Diagnosis of histomoniasis is based on a combination of clinical signs, gross pathology, histopathology, and molecular methods [1]. Clinical signs in turkeys include depression, drooping wings, inappetence, and sulfur-yellow diarrhea [1]. The characteristic cyanotic discoloration of the head (the "blackhead") is a late-stage and inconsistent finding [1]. Postmortem examination reveals the pathognomonic lesions: caseous cecal cores and focal necrotic hepatitis [1]. Histopathological examination of affected tissues confirms the presence of *H. meleagridis* trophozoites within the lesions [1]. Molecular diagnostics, particularly PCR, offer high sensitivity and specificity for detecting *H. meleagridis* DNA in cecal contents, feces, or tissues [1]. PCR is especially useful for detecting subclinical infections in carrier birds, such as chickens [1]. The use of Evans Blue Dye as an objective quantitative tool for lesion scoring provides a standardized method for assessing disease severity in experimental and diagnostic settings [10]. ## Epidemiology and Host Range Histomoniasis is a global disease, with outbreaks reported in commercial turkey flocks, backyard poultry, and wild birds [1, 2, 18, 19]. An unusual outbreak in a commercial turkey flock highlighted the potential for rapid spread and high mortality even in well-managed operations [2]. Outbreaks have also been documented in backyard Sanhuang chickens, demonstrating that the disease can occur in chicken flocks, although clinical signs are often milder than in turkeys [18]. The host range of *H. meleagridis* includes turkeys, chickens, peafowl, pheasants, and other gallinaceous birds [1, 20]. Ducks have been shown to be susceptible to experimental infection, but they are generally considered less susceptible than turkeys [20]. Wild turkeys (*Meleagris gallopavo*) are also susceptible, and histomonosis has been reported in conjunction with lymphoproliferative disease virus in male wild turkeys in Alabama, USA [19]. The role of diet in disease progression has been investigated. Dietary wheat has been shown to affect the progression of *H. meleagridis* infection in turkey poults, potentially by altering gut pH, microbiota composition, or digesta viscosity [21]. ## Control Strategies ### Chemotherapy Historically, histomoniasis was controlled by prophylactic and therapeutic use of nitroimidazoles and nitrofurans [1]. The ban on these compounds in food-producing animals in many countries has left the poultry industry with few effective chemotherapeutic options [1]. Nitarsone, an organic arsenical, was used for many years, but reduced sensitivity of *H. meleagridis* to nitarsone has been documented both *in vitro* and *in vivo*, signaling the emergence of drug resistance [3]. Several alternative compounds have been evaluated. Paromomycin, an aminoglycoside antibiotic, has shown histomonostatic activity as a feed additive in turkey poults experimentally infected with *H. meleagridis* [22]. Benzimidazole derivatives have demonstrated effectiveness for the treatment and prevention of histomonosis in turkeys [23]. Iproniazole, a nitroimidazole, has also shown antihistomonal activity [24]. Dietary Natustat, a botanical product, has been evaluated for control of *H. meleagridis* in male turkeys on infected litter, with some efficacy [25]. However, none of these alternatives provide the level of efficacy previously achieved with the banned nitroimidazoles [1]. ### Vaccination Vaccination represents a promising long-term strategy for controlling histomoniasis [1]. Several live attenuated vaccines have been developed and shown to be effective in experimental settings [13, 14, 15, 16]. A live clonal monoxenic *H. meleagridis* vaccine provides long-term protection in turkeys [15]. An *in vitro* attenuated strain provides cross-protective immunity against heterologous virulent isolates [13]. Intracloacally passaged low-virulent *H. meleagridis* also protects turkeys from histomonosis [16]. Vaccination limits pronounced changes in B cells and T-cell subsets, indicating that the protective immune response is cell-mediated [12]. ### Management and Biosecurity Effective control of histomoniasis relies on integrated management practices [1]. Key strategies include: - **Nematode control:** Reducing the population of *[Heterakis gallinarum](/knowledge/parasites/avian-parasites/heterakis-gallinarum-cecal-worm-histomonas-vector)* through strategic anthelmintic use and pasture rotation is critical for breaking the transmission cycle [1]. - **Litter management:** Maintaining dry, clean litter reduces the survival of *H. gallinarum* eggs and the risk of cloacal infection [1]. - **Biosecurity:** Preventing the introduction of carrier birds (e.g., chickens, pheasants) into turkey flocks is essential [1]. - **Separation of species:** Turkeys should not be raised on ground previously occupied by chickens or other gallinaceous birds without thorough cleaning and disinfection [1]. - **Quarantine:** New birds should be quarantined and tested before introduction to a flock [1]. The following decision tree summarizes the diagnostic and control workflow for suspected histomoniasis in a turkey flock. ```mermaid flowchart TD A["Suspected Histomoniasis in Turkey Flock"] --> B{"Clinical Signs?"} B -->|"Depression, sulfur-yellow diarrhea, mortality"| C["Postmortem Examination"] B -->|"No clinical signs"| D["Surveillance PCR on feces"] C --> E{"Gross Lesions?"} E -->|"Caseous cecal cores + necrotic hepatitis"| F["Confirm with Histopathology or PCR"] E -->|"No lesions"| G["Consider other causes"] F --> H["Confirmed Histomoniasis"] H --> I["Implement Control Measures"] I --> J["Anthelmintic treatment for Heterakis"] I --> K["Litter removal and disinfection"] I --> L["Biosecurity: separate species, quarantine"] I --> M["Consider vaccination if available"] D --> N{"PCR Positive?"} N -->|"Yes"| O["Subclinical carriers present"] O --> P["Implement biosecurity to prevent spread to turkeys"] N -->|"No"| Q["Continue routine monitoring"] ``` ## Conclusion Histomoniasis remains a major threat to turkey production worldwide due to the lack of effective chemotherapeutic agents and the high susceptibility of turkeys to the disease [1]. The parasite's reliance on the *[Heterakis gallinarum](/knowledge/parasites/avian-parasites/heterakis-gallinarum-cecal-worm-histomonas-vector)* vector for environmental transmission provides a target for control through nematode management [1]. Advances in vaccine development offer hope for a sustainable control strategy, with several live attenuated vaccines demonstrating efficacy and cross-protection in experimental trials [13, 14, 15, 16]. Continued research into the molecular biology, immunology, and epidemiology of *H. meleagridis* is essential for developing improved diagnostic tools and control measures [4, 6, 7, 8, 10, 11, 17]. ## References [1] Liebhart D, Hess M. Spotlight on Histomonosis (blackhead disease): a re-emerging disease in turkeys and chickens. *Avian Pathol*. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/31393162/ [2] Popp C, Hauck R, Blazey B, et al. An unusual outbreak of histomonosis in a commercial turkey flock. *Berl Munch Tierarztl Wochenschr*. 2012. URL: https://pubmed.ncbi.nlm.nih.gov/22515034/ [3] Abraham M, McDougald LR, Beckstead RB. Blackhead disease: reduced sensitivity of [Histomonas meleagridis](/knowledge/parasites/avian-parasites/histomonas-meleagridis-turkeys-diagnosis-therapeutic-options) to nitarsone in vitro and in vivo. *Avian Dis*. 2014. URL: https://pubmed.ncbi.nlm.nih.gov/24758114/ [4] Szekeres S, Takács N, Ózsvári L, et al. Molecular investigation of hindgut flagellates from turkeys and pheasants in Hungary confirms the endemicity of a new species closely related to [Histomonas meleagridis](/knowledge/parasites/avian-parasites/histomonas-meleagridis-blackhead-disease-turkeys). *Acta Vet Hung*. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40668647/ [5] Hess M, Grabensteiner E, Liebhart D. Rapid transmission of the protozoan parasite [Histomonas meleagridis in turkeys](/knowledge/parasites/avian-parasites/histomonas-meleagridis-turkeys-diagnosis-therapeutic-options) and specific pathogen free chickens following cloacal infection with a mono-eukaryotic culture. *Avian Pathol*. 2006. URL: https://pubmed.ncbi.nlm.nih.gov/16854640/ [6] Abdelhamid MK, Rychlik I, Hess C, et al. Typhlitis induced by [Histomonas meleagridis](/knowledge/parasites/avian-parasites/histomonas-meleagridis-turkeys-diagnosis-therapeutic-options) affects relative but not the absolute Escherichia coli counts and invasion in the gut in turkeys. *Vet Res*. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34158121/ [7] Rafieian-Naeini HR, Keshavareddy VPR, Katha HR, et al. Does Salmonella co-infection worsen [Histomonas meleagridis](/knowledge/parasites/avian-parasites/histomonas-meleagridis-blackhead-disease-turkeys) infection in turkeys? *Poult Sci*. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41759468/ [8] Rafieian-Naeini HR, Fudge C, Gudidoddi SR, et al. Disrupted gut microbiota, suppressed inflammation, and impaired bone health in turkey poults challenged with [Histomonas meleagridis](/knowledge/parasites/avian-parasites/histomonas-meleagridis-turkeys-diagnosis-therapeutic-options) and co-infected with Eimeria and E. coli. *Poult Sci*. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41218556/ [9] Powell FL, Rothwell L, Clarkson MJ, et al. The turkey, compared to the chicken, fails to mount an effective early immune response to [Histomonas meleagridis](/knowledge/parasites/avian-parasites/histomonas-meleagridis-blackhead-disease-turkeys) in the gut. *Parasite Immunol*. 2009. URL: https://pubmed.ncbi.nlm.nih.gov/19493211/ [10] Rafieian-Naeini HR, Kim WK. Research note: Evans Blue Dye as an objective quantitative tool for lesion scoring in Eimeria and [Histomonas meleagridis](/knowledge/parasites/avian-parasites/histomonas-meleagridis-turkeys-diagnosis-therapeutic-options) infected poultry. *Poult Sci*. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41855806/ [11] Durairaj V, Veen RV. Serum Biochemistry of Turkeys Challenged with [Histomonas meleagridis](/knowledge/parasites/avian-parasites/histomonas-meleagridis). *Avian Dis*. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41003438/ [12] Mitra T, Gerner W, Kidane FA, et al. Vaccination against histomonosis limits pronounced changes of B cells and T-cell subsets in turkeys and chickens. *Vaccine*. 2017. URL: https://pubmed.ncbi.nlm.nih.gov/28662952/ [13] Sulejmanovic T, Bilic I, Hess M, et al. An in vitro attenuated strain of Histomonas meleagridis provides cross-protective immunity in turkeys against heterologous virulent isolates. *Avian Pathol*. 2016. URL: https://pubmed.ncbi.nlm.nih.gov/26542637/ [14] Hess M, Liebhart D, Grabensteiner E, et al. Cloned Histomonas meleagridis passaged in vitro resulted in reduced pathogenicity and is capable of protecting turkeys from histomonosis. *Vaccine*. 2008. URL: https://pubmed.ncbi.nlm.nih.gov/18586362/ [15] Hatfaludi T, Rezaee MS, Vlerick L, et al. Long-term protection of turkeys with a live clonal monoxenic Histomonas meleagridis vaccine. *Avian Pathol*. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40406918/ [16] Nguyen Pham AD, De Gussem JK, Goddeeris BM. Intracloacally passaged low-virulent Histomonas meleagridis protects turkeys from histomonosis. *Vet Parasitol*. 2013. URL: https://pubmed.ncbi.nlm.nih.gov/23587402/ [17] Munan S, Yoval-Sánchez B, Yao C, et al. Biochemical characterization of a flavodiiron protein from bird parasite Histomonas meleagridis: superoxide as a reaction intermediate. *J Biol Chem*. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40914251/ [18] Liu D, Kong L, Tao J, et al. An Outbreak of Histomoniasis in Backyard Sanhuang Chickens. *Korean J Parasitol*. 2018. URL: https://pubmed.ncbi.nlm.nih.gov/30630281/ [19] Ostrander KN, Day MS, Hauck R, et al. Histomonosis and Lymphoproliferative Disease Virus in Male Wild Turkeys (Meleagris gallopavo) in Alabama, USA. *J Wildl Dis*. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41139422/ [20] Callait-Cardinal MP, Chauve C, Reynaud MC, et al. Infectivity of Histomonas meleagridis in ducks. *Avian Pathol*. 2006. URL: https://pubmed.ncbi.nlm.nih.gov/16595302/ [21] Rafieian-Naeini HR, Keshavareddy VPR, Katha HR, et al. Effect of dietary wheat on the progression of Histomonas meleagridis infection in turkey poults. *Poult Sci*. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42056825/ [22] Hafez HM, Hauck R, Gad W, et al. Pilot study on the efficacy of paromomycin as a histomonostatic feed additive in turkey poults experimentally infected with Histomonas meleagridis. *Arch Anim Nutr*. 2010. URL: https://pubmed.ncbi.nlm.nih.gov/20496863/ [23] Hegngi FN, Doerr J, Cummings TS, et al. The effectiveness of benzimidazole derivatives for the treatment and prevention of histomonosis (blackhead) in turkeys. *Vet Parasitol*. 1999. URL: https://pubmed.ncbi.nlm.nih.gov/9950326/ [24] Mitrovic M, Schildknecht EG. Antihistomonal activity of ipronidazole in turkeys. *Poult Sci*. 1970. URL: https://pubmed.ncbi.nlm.nih.gov/5462253/ [25] Duffy CF, Sims MD, Power RF. Evaluation of dietary Natustat for control of Histomonas meleagridis in male turkeys on infected litter. *Avian Dis*. 2005. URL: https://pubmed.ncbi.nlm.nih.gov/16252499/ ## Related Clinical & Scientific Guides * [Tick-Borne Diseases in Dogs: Pathogens, Clinical Signs, Diagnosis, and Prevention](/knowledge/parasites/general/tick-borne-diseases-dogs) * [Toxoplasmosis in Cats and the Risk of Brain Infection in Humans](/knowledge/parasites/general/toxoplasmosis-cats-brain-infection-humans) * [Dog Heartworm and Tick-Borne Disease Prevention](/knowledge/parasites/general/dog-heartworm-and-tick-borne-disease-prevention)